BAXDELA (delafloxacin) | Your Path Forward
BAXDELA® is indicated in adults for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP) caused by designated susceptible bacteria.
BAXDELA (delafloxacin) ABSSSI | About Baxdela
Explore the path forward with BAXDELA for the treatment of ABSSSI caused by susceptible gram -/+ pathogens, including MRSA. See BOXED WARNING.
BAXDELA (delafloxacin) | Efficacy
BAXDELA® is indicated in adults for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP) caused by designated susceptible bacteria.
BAXDELA is indicated in adults for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by the following susceptible microorganisms: Staphylococcus aureus (including methicillin-resistant [MRSA] and methicillin-susceptible [MSSA] isolates), Staphylococcus haemolyticus, Staphylococcus lugdunensis, Streptococcus ...
BAXDELA (delafloxacin) | Dosing and Administration
BAXDELA® is indicated in adults for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP) caused by …
BAXDELA (delafloxacin) | Safety | Tolerability
To reduce the development of drug-resistant bacteria and maintain the effectiveness of BAXDELA and other antibacterial drugs, BAXDELA should be used only to treat infections that are …
See “What is the most important information I should know about BAXDELA?” Before you take BAXDELA, tell your healthcare provider about all your medical conditions, including if you: tendon problems. BAXDELA should not be used in patients who have a history of sthenia gravis). BAXDELA should not be used in patients who have a history of m
BAXDELA (delafloxacin) | Mechanism of Action
BAXDELA® is indicated in adults for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP) caused by …
BAXDELA (delafloxacin) | About Melinta
BAXDELA® is indicated in adults for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP) caused by …
BAXDELA (delafloxacin) | Microbiological Activity in ABSSSI
BAXDELA® is indicated in adults for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP) caused by designated susceptible bacteria.